Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
- PMID: 8756719
- DOI: 10.1016/s0092-8674(00)80110-5
Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
Abstract
Rare individuals have been multiply exposed to HIV-1 but remain uninfected. The CD4+ T-cells of two of these individuals, designated EU2 and EU3, are highly resistant in vitro to the entry of primary macrophagetropic virus but are readily infectable with transformed T-cell line adapted viruses. We report here on the genetic basis of this resistance. We found that EU2 and EU3 have a homozygous defect in CKR-5, the gene encoding the recently described coreceptor for primary HIV-1 isolates. These individuals appear to have inherited a defective CKR-5 allele that contains an internal 32 base pair deletion. The encoded protein is severely truncated and cannot be detected at the cell surface. Surprisingly, this defect has no obvious phenotype in the affected individuals. Thus, a CKR-5 allele present in the human population appears to protect homozygous individuals from sexual transmission of HIV-1. Heterozygous individuals are quite common (approximately 20%) in some populations. These findings indicate the importance of CKR-5 in HIV-1 transmission and suggest that targeting the HIV-1-CKR-5 interaction may provide a means of preventing or slowing disease progression.
Similar articles
-
Mutant gene blocks HIV's entry into cells.NIAID AIDS Agenda. 1996 Sep:6. NIAID AIDS Agenda. 1996. PMID: 11363925
-
Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.Science. 1996 Sep 27;273(5283):1856-62. doi: 10.1126/science.273.5283.1856. Science. 1996. PMID: 8791590
-
HIV-1 infection in an individual homozygous for the CCR5 deletion allele.Nat Med. 1997 Mar;3(3):252-3. doi: 10.1038/nm0397-252. Nat Med. 1997. PMID: 9055842 No abstract available.
-
Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele.Emerg Infect Dis. 1997 Jul-Sep;3(3):261-71. doi: 10.3201/eid0303.970302. Emerg Infect Dis. 1997. PMID: 9284370 Free PMC article. Review.
-
Coreceptor-Based Hematopoietic Stem Cell Gene Therapy for HIV Disease.Curr Stem Cell Res Ther. 2019;14(7):591-597. doi: 10.2174/1574888X14666190523094556. Curr Stem Cell Res Ther. 2019. PMID: 31120000 Review.
Cited by
-
Combinatorial RNA-based gene therapy for the treatment of HIV/AIDS.Expert Opin Biol Ther. 2013 Mar;13(3):437-45. doi: 10.1517/14712598.2013.761968. Expert Opin Biol Ther. 2013. PMID: 23394377 Free PMC article. Review.
-
A novel approach to quantify G-protein-coupled receptor dimerization equilibrium using bioluminescence resonance energy transfer.Methods Mol Biol. 2013;1013:93-127. doi: 10.1007/978-1-62703-426-5_7. Methods Mol Biol. 2013. PMID: 23625495 Free PMC article.
-
Altering cell death pathways as an approach to cure HIV infection.Cell Death Dis. 2013 Jul 11;4(7):e718. doi: 10.1038/cddis.2013.248. Cell Death Dis. 2013. PMID: 23846220 Free PMC article. Review.
-
Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission.Nat Commun. 2021 Jun 7;12(1):3343. doi: 10.1038/s41467-021-23697-6. Nat Commun. 2021. PMID: 34099693 Free PMC article.
-
Peptide and protein-based inhibitors of HIV-1 co-receptors.Exp Biol Med (Maywood). 2013 May;238(5):442-9. doi: 10.1177/1535370213480696. Exp Biol Med (Maywood). 2013. PMID: 23856897 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
